AASLD guidelines for treatment of chronic hepatitis B
Open Access
- 13 November 2015
- journal article
- practice guideline
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hepatology
- Vol. 63 (1), 261-283
- https://doi.org/10.1002/hep.28156
Abstract
No abstract availableKeywords
Funding Information
- American Association for the Study of Liver Diseases
This publication has 121 references indexed in Scilit:
- Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virusBMC Pregnancy and Childbirth, 2013
- Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-upClinical Infectious Diseases, 2012
- Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-AnalysisPLOS ONE, 2012
- Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Côte d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2Antimicrobial Agents and Chemotherapy, 2011
- A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virusWorld Journal of Gastroenterology, 2011
- SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver DiseaseGastroenterology, 2010
- Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside‐naive Chinese chronic hepatitis B patientsJournal of Viral Hepatitis, 2010
- Tenofovir Disoproxil FumarateDrugs, 2009
- HBeAg seroconversion as an important end point in the treatment of chronic hepatitis BHepatology International, 2009
- Antiretroviral Concentrations in Breast-Feeding Infants of Mothers Receiving Highly Active Antiretroviral TherapyAntimicrobial Agents and Chemotherapy, 2009